DrugCite
Search

DIANEAL LOW CALCIUM WITH DEXTROSE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Dianeal Low Calcium With Dextrose Adverse Events Reported to the FDA Over Time

How are Dianeal Low Calcium With Dextrose adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Dianeal Low Calcium With Dextrose, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Dianeal Low Calcium With Dextrose is flagged as the suspect drug causing the adverse event.

Most Common Dianeal Low Calcium With Dextrose Adverse Events Reported to the FDA

What are the most common Dianeal Low Calcium With Dextrose adverse events reported to the FDA?

Death
620 (15.13%)
Pneumonia
127 (3.1%)
Cardiac Failure
121 (2.95%)
Myocardial Infarction
112 (2.73%)
Sepsis
80 (1.95%)
Cerebrovascular Accident
75 (1.83%)
Cardiac Disorder
68 (1.66%)
Hypotension
66 (1.61%)
Fall
65 (1.59%)
Infection
56 (1.37%)
Dyspnoea
53 (1.29%)
Show More Show More
Peritoneal Dialysis Complication
52 (1.27%)
Dehydration
51 (1.24%)
Vomiting
51 (1.24%)
Asthenia
48 (1.17%)
Malaise
45 (1.1%)
Peritonitis
43 (1.05%)
Chest Pain
41 (1%)
Peritonitis Bacterial
40 (.98%)
Cardiac Arrest
39 (.95%)
Hernia
39 (.95%)
Nausea
39 (.95%)
Hypertension
33 (.81%)
Respiratory Failure
31 (.76%)
Anaemia
30 (.73%)
Cardiac Failure Congestive
27 (.66%)
Cerebral Haemorrhage
27 (.66%)
Pulmonary Oedema
27 (.66%)
Pyrexia
27 (.66%)
Gangrene
26 (.63%)
Abdominal Distension
25 (.61%)
Therapy Cessation
24 (.59%)
Localised Infection
23 (.56%)
Thrombosis
21 (.51%)
Diarrhoea
20 (.49%)
Oedema
20 (.49%)
Pleural Effusion
20 (.49%)
Catheter Site Infection
19 (.46%)
Gastrointestinal Haemorrhage
19 (.46%)
Renal Failure
19 (.46%)
Fungal Peritonitis
18 (.44%)
Cerebral Infarction
17 (.41%)
Constipation
17 (.41%)
Convulsion
17 (.41%)
Fluid Overload
17 (.41%)
Urinary Tract Infection
17 (.41%)
Abdominal Pain
16 (.39%)
Back Pain
14 (.34%)
Blood Potassium Decreased
14 (.34%)
Loss Of Consciousness
14 (.34%)
Blood Pressure Decreased
13 (.32%)
Clostridial Infection
13 (.32%)
Hip Fracture
13 (.32%)
Syncope
13 (.32%)
Bloody Peritoneal Effluent
12 (.29%)
Dizziness
12 (.29%)
Marasmus
12 (.29%)
Abscess
11 (.27%)
Blindness
11 (.27%)
Cardio-respiratory Arrest
11 (.27%)
Cardiovascular Disorder
11 (.27%)
Haemoglobin Decreased
11 (.27%)
Discomfort
10 (.24%)
Gallbladder Disorder
10 (.24%)
Influenza
10 (.24%)
Injury
10 (.24%)
Oedema Peripheral
10 (.24%)
Procedural Pain
10 (.24%)
Treatment Noncompliance
10 (.24%)
Blood Glucose Increased
9 (.22%)
Confusional State
9 (.22%)
Decreased Appetite
9 (.22%)
Deep Vein Thrombosis
9 (.22%)
Fluid Retention
9 (.22%)
Foot Fracture
9 (.22%)
Headache
9 (.22%)
Hypoglycaemia
9 (.22%)
Lung Infection
9 (.22%)
Mycobacterium Abscessus Infection
9 (.22%)
Neoplasm Malignant
9 (.22%)
Pain
9 (.22%)
Procedural Complication
9 (.22%)
Pulmonary Embolism
9 (.22%)
Road Traffic Accident
9 (.22%)
Skin Ulcer
9 (.22%)
Angiopathy
8 (.2%)
Arrhythmia
8 (.2%)
Atrial Fibrillation
8 (.2%)
Blood Potassium Increased
8 (.2%)
Gastrointestinal Infection
8 (.2%)
General Physical Health Deteriorati...
8 (.2%)
Intestinal Perforation
8 (.2%)
Mental Disorder
8 (.2%)
Peripheral Vascular Disorder
8 (.2%)
Post Procedural Complication
8 (.2%)
Rectal Haemorrhage
8 (.2%)
Spinal Fracture
8 (.2%)
Staphylococcal Infection
8 (.2%)
Weight Increased
8 (.2%)
Abdominal Pain Upper
7 (.17%)
Azotaemia
7 (.17%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Dianeal Low Calcium With Dextrose, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Dianeal Low Calcium With Dextrose is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Dianeal Low Calcium With Dextrose

What are the most common Dianeal Low Calcium With Dextrose adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Dianeal Low Calcium With Dextrose, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Dianeal Low Calcium With Dextrose is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Dianeal Low Calcium With Dextrose According to Those Reporting Adverse Events

Why are people taking Dianeal Low Calcium With Dextrose, according to those reporting adverse events to the FDA?

Peritoneal Dialysis
1890
Renal Failure Chronic
248
Diabetic Nephropathy
10
Renal Failure
7
Glomerulonephritis Chronic
4
Renal Cyst
2
Show More Show More
Nephrosclerosis
2
Azotaemia
1
Diabetic Neuropathy
1
Congenital Cystic Kidney Disease
1
Glomerulonephritis
1
Gastric Lavage
1

Drug Labels

LabelLabelerEffective
Dianeal Low Calcium With DextroseBaxter Healthcare Corporation12-FEB-02

Dianeal Low Calcium With Dextrose Case Reports

What Dianeal Low Calcium With Dextrose safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Dianeal Low Calcium With Dextrose. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Dianeal Low Calcium With Dextrose.